Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Master's Award: Canada Graduate Scholarships

McMaster University

$17,500.00

Generation of a chemotherapy-induced peripheral neuropathy model for small molecule screening of axonopathy inhibitors

FY 2014-15

Summary
" Chemotherapy-induced peripheral neuropathy (CIPN) is a condition seen in patients undergoing chemotherapy treatment for cancer and results in damage to the nerves responsible for the sensation of pain. Approximately 30-40% of patients undergoing chemotherapy are affected, which leads to early stoppage of treatment, increased risk of cancer return, and decreased survival rates. These chemotherapy drugs are damaging to nerves, disrupting their normal function and causing symptoms of increased or decreased sensitivity to pain, and abnormal feelings or pain. Additionally, sensations of tingling, tickling, burning, pricking, or “pins and needles” may occur. As a result, CIPN can be tremendously painful and disabling, causing significant loss of functional abilities and decreased quality of life. Easy to acquire blood samples will be “reprogrammed” into cells that are capable of sensory nerve function, and will be treated with chemotherapy drugs to artificially create CIPN in these cells to serve as a model of the condition. These nerves will be used in small molecule screening for drugs capable of stopping the nerve damage and degeneration. The effect of the small molecules on healthy cells will be monitored to make sure there is no debilitating effect on non-affected cells. Finding drugs that can stop nerve damage in chemotherapy patients without limiting the effect of current treatments will be beneficial in developing strategies to combat cancer and CIPN."
Program
Master's Award: Canada Graduate Scholarships
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
332602
Name
Jones Michelle L
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Generation of a chemotherapy-induced peripheral neuropathy model for small molecule screening of axonopathy inhibitors
Programtype2
Studentship Programs
Orgnameinp2
McMaster University
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Drug Screening; Neuronal Modeling; Neuropathy; Neurotoxicity; Reprogramming
Abstract
" Chemotherapy-induced peripheral neuropathy (CIPN) is a condition seen in patients undergoing chemotherapy treatment for cancer and results in damage to the nerves responsible for the sensation of pain. Approximately 30-40% of patients undergoing chemotherapy are affected, which leads to early stoppage of treatment, increased risk of cancer return, and decreased survival rates. These chemotherapy drugs are damaging to nerves, disrupting their normal function and causing symptoms of increased or decreased sensitivity to pain, and abnormal feelings or pain. Additionally, sensations of tingling, tickling, burning, pricking, or “pins and needles” may occur. As a result, CIPN can be tremendously painful and disabling, causing significant loss of functional abilities and decreased quality of life. Easy to acquire blood samples will be “reprogrammed” into cells that are capable of sensory nerve function, and will be treated with chemotherapy drugs to artificially create CIPN in these cells to serve as a model of the condition. These nerves will be used in small molecule screening for drugs capable of stopping the nerve damage and degeneration. The effect of the small molecules on healthy cells will be monitored to make sure there is no debilitating effect on non-affected cells. Finding drugs that can stop nerve damage in chemotherapy patients without limiting the effect of current treatments will be beneficial in developing strategies to combat cancer and CIPN."
Competitiondate
201412
Approvedterm2
1 yr 0 mth
Pinamesdelim
Jones, Michelle L
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~